Search

everythinglearnresearchcommunity

for

Search:↓

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Zinc can help with some skin problems, but its effectiveness varies depending on the condition.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

HIV can cause unusual and severe skin problems that are hard to treat.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Hair follicles prevent NK cell attacks to avoid hair loss.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Zinc is crucial for skin health and treating various skin disorders.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Iron deficiency might contribute to hair loss in women.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.